Hiroki Kobayashi, Yoshiaki Abe, Daisuke Miura, Kentaro Narita, Akihiro Kitadate, Masami Takeuchi, Kosei Matsue (Hematology, Kameda Medical Center, Chiba, Japan)

Tetsuya Kobayashi, Yoshiaki Abe, Kentaro Narita, Hiroki Kobayashi, Akihiro Kitadate, Masami Takeuchi, Kosei Matsue (Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center)

Hiroki Kobayashi, Yoshiaki Abe, Daisuke Miura, Kentaro Narita, Akihiro Kitadate, Masami Takeuchi, Kosei Matsue (Hematology, Kameda Medical Center, Chiba, Japan)

Yoshiaki Abe, Kentaro Narita, Hiroki Kobayashi, Akihiro Kitadate, Masami Takeuchi, Kosei Matsue (Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center)

Hirokazu Tanaka^1,22, Kentaro Serizawa^1,23, Aya Nakaya^2,23, Hitomi Kaneko^3,23, Kensuke Ohta^4,23, Satoru Kosugi^5,23, Hideo Yagi^6,23, Hitoshi Hanamoto^7,23, Shin-Ichi Fuchida^8,23, Yuji Shimura^9,23, Hirohiko Shibayama^10,23, Takae Kohara^10,23, Eiji Nakatani^11,23, Junya Kanda^12,23, Nobuhiko Uoshima^13,23, Katsuya Wada^14,23, Takahiro Karasuno^15,23, Toshimitsu Matsui^16,23, Hitoji Uchiyama^17,23, Mitsuhiro Matsuda^18,23, Yoko Adachi^19,23, Akifumi Takaori-Kondo^12,23, Junya Kuroda^9,23, Masafumi Taniwaki^20,23, Chihiro Shimazaki^8,23, Masayuki Hino^21,23, Kazunori Imada^3,23, Shosaku Nomura^22,23, Yuzuru Kanakura^10,23, Itaru Matsumura^1,23 (1.Hematolog and Rheumatology, Kindai University, Osaka, Japan, 2.Hematology and Oncology, Kansai Medical University Medical Center, Osaka, Japan, 3.Hematology, Osaka Red Cross Hospital, Osaka, Japan, 4.Hematology, Osaka Saiseikai Nakatsu Hospital, Osaka, Japan, 5.Internal Medicine (Hematology), Toyonaka Municipal Hospital, Osaka, Japan, 6.Hematology and Oncology, Nara Prefecture General Medical Center, Nara, Japan, 7.Hematology, Kindai University Nara Hospital, Nara, Japan, 8.Hematology, JCHO Kyoto Kuramaguchi Medical Center, Kyoto, Japan, 9.Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan, 10.Hematology and Oncology, Osaka University, Osaka, Japan, 11.Biostatistics and Data Science, Osaka University, Osaka, Japan, 12.Hematology and Oncology, Kyoto University, Kyoto, Japan, 13.Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan, 14.Hematology, Matsushita Memorial Hospital, Osaka, Japan, 15.Hematology, Rinku General Medical Center, Osaka, Japan, 16.Hematology, Nishiwaki Municipal Hospital, Hyogo, Japan, 17.Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan, 18.Hematology, PL General Hospital, Osaka, Japan, 19.Hematology, Kobe Central Hospital, Hyogo, Japan, 20.Molecular Diagnostics Therapeutics, Kyoto Prefectural University of Medicine, Kyoto, Japan, 21.Hematology, Osaka City University, Osaka, Japan, 22.First Department of Internal Medicine, Kansai Medical University, Osaka, Japan, 23.Kansai Myeloma Forum, Osaka, Japan)

Takaaki Cho¹, Shuusaku Matsuda², Izumi Mishiro², Junpei Soeda², Kenshi Suzuki³ (1.Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata, Japan, 2.Japan Medical Affairs, Takeda Pharmaceuticals Company Limited, Tokyo, Japan, 3.Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan)